|
1
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wan DS: Epidemiologic trend of and
strategies for colorectal cancer. Ai Zheng. 28:897–902. 2009.(In
Chinese). PubMed/NCBI
|
|
3
|
van Dam J and Friedman LS: Missed cancers
at colonscopy: Learning the hard way. Gastrointest Endosc.
45:530–533. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen K and Rajewsky N: The evolution of
gene regulation by transcription factors and microRNAs. Nat Rev
Genet. 8:93–103. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bhaumik D, Scott GK, Schokrpur S, Patil
CK, Campisi J and Benz CC: Expression of microRNA-146 suppresses
NF-kappaB activity with reduction of metastatic potential in breast
cancer cells. Oncogene. 27:5643–5647. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Abella V, Valladares M, Rodriguez T, Haz
M, Blanco M, Tarrío N, Iglesias P, Aparicio LA and Figueroa A:
MiR-203 regulates cell proliferation through its influence on Hakai
expression. PLoS One. 7:e525682012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li J, Huang H, Sun L, Yang M, Pan C, Chen
W, Wu D, Lin Z, Zeng C, Yao Y, et al: MiR-21 indicates poor
prognosis in tongue squamous cell carcinomas as an apoptosis
inhibitor. Clin Cancer Res. 15:3998–4008. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lanza G, Ferracin M, Gafà R, Veronese A,
Spizzo R, Pichiorri F, Liu CG, Calin GA, Croce CM and Negrini M:
Mrna/MicroRNAs gene expression profile in microsatellite unstable
colorectal cancer. Mol Cancer. 6:542007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Link A, Balaguer F, Shen Y, Nagasaka T,
Lozano JJ, Boland CR and Goel A: Fecal MicroRNAs as novel
biomarkers for colon cancer screening. Cancer Epidemiol Biomarkers
Prev. 19:1766–1774. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Asangani IA, Rasheed SA, Nikolova DA,
Leupold JH, Colburn NH, Post S and Allgayer H: Microrna-21 (mir-21)
post-transcriptionally downregulates tumor suppressor pdcd4 and
stimulates invasion, intravasation and metastasis in colorectal
cancer. Oncogene. 27:2128–2136. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gilad S, Meiri E, Yogev Y, Benjamin S,
Lebanony D, Yerushalmi N, Benjamin H, Kushnir M, Cholakh H, Melamed
N, et al: Serum microRNAs are promising novel biomarkers. PLoS One.
3:e31482008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schrauder MG, Strick R, Schulz-Wendtland
R, Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A,
Hein A, et al: Circulating micro-RNAs as potential blood-based
markers for early stage breast cancer detection. PLoS One.
7:e297702012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ng EK, Chong WW, Jin H, Lam EK, Shin VY,
Yu J, Poon TC, Ng SS and Sung JJ: Differential expression of
microRNAs in plasma of patients with colorectal cancer: A potential
marker for colorectal cancer screening. Gut. 58:1375–1381. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Majid S, Dar AA, Saini S, Arora S,
Shahryari V, Zaman MS, Chang I, Yamamura S, Tanaka Y, Deng G and
Dahiya R: MiR-23b represses proto-oncogene Src kinase and functions
as methylation-silenced tumor suppressor with diagnostic and
prognostic significance in prostate cancer. Cancer Res.
72:6435–6446. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Salvi A, Sabelli C, Moncini S, Venturin M,
Arici B, Riva P, Portolani N, Giulini SM, De Petro G and Barlati S:
MicroRNA-23b mediates urokinase and c-met downmodulation and a
decreased migration of human hepatocellular carcinoma cells. FEBS
J. 276:2966–2982. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Loftus JC, Ross JT, Paquette KM, Paulino
VM, Nasser S, Yang Z, Kloss J, Kim S, Berens ME and Tran NL: MiRNA
expression profiling in migrating glioblastoma cells: Regulation of
cell migration and invasion by miR- 23b via targeting of Pyk2. PLoS
One. 7:e398182012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li W, Liu Z, Chen L, Zhou L and Yao Y:
MicroRNA-23b is an independent prognostic marker and suppresses
ovarian cancer progression by targeting runt-related transcription
factor-2. FEBS Lett. 588:1608–1615. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tong AW, Fulgham P, Jay C, Chen P, Khalil
I, Liu S, Senzer N, Eklund AC, Han J and Nemunaitis J: MicroRNA
profile analysis of human prostate cancers. Cancer Gene Ther.
16:206–216. 2009.PubMed/NCBI
|
|
21
|
Goto Y, Kojima S, Nishikawa R, Enokida H,
Chiyomaru T, Kinoshita T, Nakagawa M, Naya Y, Ichikawa T and Seki
N: The microRNA-23b/27b/24-1 cluster is a disease progression
marker and tumor suppressor in prostate cancer. Oncotarget.
5:7748–7759. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun T, Yang M, Chen S, Balk S, Pomerantz
M, Hsieh CL, Brown M, Lee GS and Kantoff PW: The altered expression
of MiR-221/-222 and MiR-23b/-27b is associated with the development
of human castration resistant prostate cancer. Prostate.
72:1093–1103. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Castilla MÁ, Moreno-Bueno G, Romero-Pérez
L, Van De Vijver K, Biscuola M, López-García MÁ, Prat J,
Matías-Guiu X, Cano A, Oliva E and Palacios J: Micro-RNA signature
of the epithelial-mesenchymal transition in endometrial
carcinosarcoma. J Pathol. 223:72–80. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang H, Hao Y, Yang J, Zhou Y, Li J, Yin
S, Sun C, Ma M, Huang Y and Xi JJ: Genome-wide functional screening
of miR-23b as a pleiotropic modulator suppressing cancer
metastasis. Nat Commun. 2:5542011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Obrocea FL, Sajin M, Marinescu EC and
Stoica D: Colorectal cancer and the 7th revision of the TNM staging
system: Review of changes and suggestions for uniform pathologic
reporting. Rom J Morphol Embryol. 52:537–544. 2011.PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou X, Xu X, Wang J, Lin J and Chen W:
dentifying miRNA/mRNA negative regulation pairs in colorectal
cancer. Sci Rep. 5:129952015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Geng J, Luo H, Pu Y, Zhou Z, Wu X, Xu W
and Yang Z: Methylation mediated silencing of miR-23b expression
and its role in glioma stem cells. Neurosci Lett. 528:185–189.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tanaka M, Oikawa K, Takanashi M, Kudo M,
Ohyashiki J, Ohyashiki K and Kuroda M: Down-regulation of miR-92 in
human plasma is a novel marker for acute leukemia patients. PLoS
One. 4:e55322009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tsujiura M, Ichikawa D, Komatsu S,
Shiozaki A, Takeshita H, Kosuga T, Konishi H, Morimura R, Deguchi
K, Fujiwara H, et al: Circulating microRNAs in plasma of patients
with gastric cancers. Br J Cancer. 102:1174–1179. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu CJ, Kao SY, Tu HF, Tsai MM, Chang KW
and Lin SC: Increase of microRNA miR-31 level in plasma could be a
potential marker of oral cancer. Oral Dis. 16:360–364. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cheng H, Zhang L, Cogdell DE, Zheng H,
Schetter AJ, Nykter M, Harris CC, Chen K, Hamilton SR and Zhang W:
Circulating plasma MiR-141 is a novel biomarker for metastatic
colon cancer and predicts poor prognosis. PLoS One. 6:e177452011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ishteiwy RA, Ward TM, Dykxhoorn DM and
Burnstein KL: The microRNA −23b/-27b cluster suppresses the
metastatic phenotype of castration-resistant prostate cancer cells.
PLoS One. 7:e521062012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang KC, Garmire LX, Young A, Nguyen P,
Trinh A, Subramaniam S, Wang N, Shyy JY, Li YS and Chien S: Role of
microRNA-23b in flow-regulation of Rb phosphorylation and
endothelial cell growth. Proc Natl Acad Sci USA. 107:3234–3239.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rogler CE, Levoci L, Ader T, Massimi A,
Tchaikovskaya T, Norel R and Rogler LE: MicroRNA-23b cluster
microRNAs regulate transforming growth factor-beta/bone
morphogenetic protein signaling and liver stem cell differentiation
by targeting smads. Hepatology. 50:575–584. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Scapoli L, Palmieri A, Lo Muzio L,
Pezzetti F, Rubini C, Girardi A, Farinella F, Mazzotta M and
Carinci F: MicroRNA expression profiling of oral carcinoma
identifies new markers of tumor progression. Int J Immunopathol
Pharmacol. 23:1229–1234. 2010.PubMed/NCBI
|
|
37
|
Chen L, Han L, Zhang K, Shi Z, Zhang J,
Zhang A, Wang Y, Song Y, Li Y, Jiang T, et al: VHL regulates the
effects of miR-23b on glioma survival and invasion via suppression
of HIF-1α/VEGF and β-catenin/Tcf-4 signaling. Neuro Oncol.
14:1026–1036. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Paris O, Ferraro L, Grober OM, Ravo M, De
Filippo MR, Giurato G, Nassa G, Tarallo R, et al: Direct regulation
of microRNA biogenesis and expression by estrogen receptor beta in
hormone-responsive breast cancer. Oncogene. 31:4196–4206. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jin L, Wessely O, Marcusson EG, Ivan C,
Calin GA and Alahari SK: Prooncogenic factors miR-23b and miR-27b
are regulated by Her2/Neu, EGF, and TNF-α in breast cancer. Cancer
Res. 73:2884–2896. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pellegrino L, Stebbing J, Braga VM,
Frampton AE, Jacob J, Buluwela L, Jiao LR, Periyasamy M, Madsen CD,
Caley MP, et al: MiR-23b regulates cytoskeletal remodeling,
motility and metastasis by directly targeting multiple transcripts.
Nucleic Acids Res. 41:5400–5412. 2013. View Article : Google Scholar : PubMed/NCBI
|
